论文部分内容阅读
心房颤动是临床中常见的心律失常,肿瘤患者在抗肿瘤治疗过程中会造成心肌损伤而可能增加心房颤动发生风险.目前在肿瘤合并心房颤动的流行病学、病理生理学机制、预后研究及治疗进展等方面有最新的研究成果.现对近年来研究进展进行综述.“,”Atrial fibrillation is one of the common arrhythmia found in clinical setting.Patients with cancer will increase their risk of newly-developed atrial fibrillation throughout anti-cancer treatments.This article reviews the current study results on the epidemiology,pathophysiological mechanisms,prognoses,and treatments of cancer and atrial fibrillation.